Produkty 1058-61-3

CAS 1058-61-3 występuje w naszej ofercie pod nazwami: Sitostenone, Sitostenone/ 98%, β–Sitostenone, β-Sitostenone, β-Sitostenone, 95.0%. Oferty producentów: Chemat Brand, TargetMol, GLPBio, Biosynth, Chemat. Dostępne opakowania: on request, 1mg, 2mg, 5mg, 10mg, 25mg, 50mg, 100mg.

Sitostenone
Chemat Brand, Biosynth
  • opakowanie: on request, 10mg, 1mg, 2mg
  • Warianty: 6
Zobacz produkt
Sitostenone/ 98%
TargetMol
  • opakowanie: 1mg, 2mg, 5mg, 10mg
  • Warianty: 7
od 757,88
Zobacz produkt
β–Sitostenone
GLPBio
  • opakowanie: 5mg
  • Warianty: 1
od 1425,49
Zobacz produkt
β-Sitostenone
Chemat
  • opakowanie: 5mg, 25mg, 100mg
  • Warianty: 3
od 582,80
Zobacz produkt
β-Sitostenone, 95.0%
MedChemExpress
  • opakowanie: 1 mg, 5 mg
  • Warianty: 2
od 649,42
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 1058-61-3) to związek chemiczny o wzorze sumarycznym C29H48O i masie molowej 412.7 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: RUVUHIUYGJBLGI-XJZKHKOHSA-N.

Dane identyfikacyjne
Wzór sumarycznyC29H48O
Masa molowa412.7 g/mol
Nazwa IUPAC(8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyRUVUHIUYGJBLGI-XJZKHKOHSA-N
SMILESCC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Stigmast-4-en-3-one, Stigmast-4-en-3-one (8CI), Sitostenone, beta-sitostenone, 4-Stigmasten-3-one, 24-Eceo, 24-Ethyl-4-cholesten-3-one, gamma-sitostenone, ?-Sitostenone, |?-Sitostenone
Izomery (ten sam wzór sumaryczny)
(3S,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H48O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(E,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H48O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(Z,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H48O
(3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R)-5-ethyl-6-methylhept-4-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H48O
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-ethyl-6-methylhept-6-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H48O
(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(Z,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H48O
(3S,8S,9S,10R,13R,14S,17R)-17-(5-ethyl-6-methylhept-5-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H48O
(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(Z,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H48O
(3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H48O
(3S,5R,10S,13R,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7,11,12,16,17-decahydrocyclopenta[a]phenanthren-3-ol C29H48O
(3S,9S,10R,13R,14R,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-ol C29H48O
(3S,10S,13R,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7,11,12,16,17-decahydrocyclopenta[a]phenanthren-3-ol C29H48O